Alcohol septal ablation 2000-2001
Websites
TCT 2001 Featured Presentations
TCTMD - Fellows Course Slide Sets
Regression of left ventricular hypertrophy
after nonsurgical septal reduction therapy for hypertrophic obstructive
cardiomyopathy
Mazur W, et al.
Circulation 2001;103:1492-6
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11257074
Clinical Cardiology: New Frontiers
New Concepts in Hypertrophic Cardiomyopathies, Part I
Robert Roberts and Ulrich Sigwart
Circulation 2001;104 2113-2116
http://circ.ahajournals.org/cgi/content/full/104/17/2113
Clinical Cardiology: New Frontiers
New Concepts in Hypertrophic Cardiomyopathies, Part II
Robert Roberts and Ulrich Sigwart
Circulation 2001;104 2249-2252
http://circ.ahajournals.org/cgi/content/full/104/18/2249
Anatomy of the first septal perforating
artery: a study with implications for ablation therapy for hypertrophic
cardiomyopathy
Singh M, et al.
Mayo Clin Proc 2001;76:799-802
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11499819
Microvascular obstruction after nonsurgical
septal reduction for the treatment of hypertrophic cardiomyopathy
Wu KC, et al.
Circulation 2001;104:1868
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11591628
Efficacy of nonsurgical septal reduction
therapy in symptomatic patients with obstructive hypertrophic cardiomyopathy and
provocable gradients
Lakkis N, et al.
Am J Cardiol 2001;88:583-6
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11524078
Pressure-guided nonsurgical myocardial
reduction induced by small septal infarctions in hypertrophic obstructive
cardiomyopathy
Boekstegers P, et al.
J Am Coll Cardiol 2001;38:846-53
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11527644
Pressure-guided NSMR inducing small septal infarctions was sufficient to result
in a sustained decrease in LVOT obstruction and to improve symptoms. The
incidence of complications, such as complete heart block with necessary
permanent pacemaker implantation (<10%), seems to be diminished by minimizing
the infarct size.
Progressive decrease of outflow gradient and septum thickness after percutaneous alcoholization of the interventricular septum in hypertrophic obstructive cardiomyopathy
Airoldi F et al.
Ital Heart J 2000;1:200-6
http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?db=m&form=6&dopt=r&uid=0010806987
Click here to view the full article
PTSMA of the intraventricular septum effectively relieves symptoms in selected patients with hypertrophic obstructive
cardiomyopathy. The immediate decrease in intraventricular gradient is followed by a further decline at follow-up with a progressive reduction in the intraventricular septum
thickness.
Alcohol septal ablation in hypertrophic obstructive cardiomyopathy: The need for a registry
W. Spencer R. Roberts
Circulation 2000; 102: 600-1
Click here
Nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy: one-year follow-up
Lakkis NM Nagueh SF Dunn JK, Killip D Spencer WH 3rd
J Am Coll Cardiol 2000; 36: 852-5
http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?db=m&form=6&dopt=r&uid=0010987610
Nonsurgical septal reduction therapy is a safe, rational and effective therapy for symptomatic patients with hypertrophic obstructive
cardiomyopathy. Favorable outcomes were found up to one year after the procedure on first 50 hypertrophic obstructive cardiomyopathy patients to undergo nonsurgical septal reduction therapy in the United
States.
Click here to view the full article
synopsis.
Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy: long term follow up of the first series of 25 patients
Faber L et al.
Heart 2000;83:326-31
http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?db=m&form=6&dopt=r&uid=0010677415
PTSMA is an effective non-surgical technique for reduction of symptoms and LVOTG in
HOCM. Prospective, long term observations of larger populations are necessary in order to determine the definitive significance of the procedure.
Role of alcohol septal ablation in treatment of obstructive hypertrophic cardiomyopathy
Maron BJ
Lancet 2000;355:425-6
http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?db=m&form=6&dopt=r&uid=0010841119
Percutaneous transluminal septal myocardial ablation: a new treatment for hypertrophic obstructive cardiomyopathy
Seggewiss H
Eur Heart J 2000;21:704-7
http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?db=m&form=6&dopt=r&uid=0010739723